Teva Pharmaceutical Industries Ltd. is transitioning its stock from American Depositary Shares (ADS) to a direct listing on the NYSE.
6 reports, 5 independent
Updated Sep 14
Gone quiet
- Reports
- 6
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Teva Pharmaceutical Industries Ltd. is transitioning its stock from American Depositary Shares (ADS) to a direct listing on the NYSE.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Teva shares start trading directly on the NYSE following its transition from ADS.1 source
Market activity regarding Teva stock, including analyst rating lifts and institutional buying.1 source
Teva is moving from ADS to a direct listing on the New York Stock Exchange.1 source
Keep exploring
The entities involved
-
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
Nothing else this week.
-
New York Stock Exchange
American stock exchange
Related events
- Multiple companies, including Teva Pharmaceutical Industries and Woodside Energy, held corporate events at the New York Stock Exchange on November 11, 2026.
- OPay ADSs are expected to trade on the New York Stock Exchange, with Needham & Company acting as co-manager.
- AstraZeneca listed shares on the New York Stock Exchange to attract investors.
- Kraft Heinz is planning to transfer its listing from Nasdaq to the NYSE, accompanied by SEC filings regarding ownership changes.
- A company whose CEOs are merging is utilizing both the NYSE and Nasdaq as potential listing venues, with operations spanning Maryland and Pennsylvania.